Madrigal Pharmaceuticals (MDGL) Non-Current Deferred Tax Liability (2016 - 2020)

Madrigal Pharmaceuticals (MDGL) has 3 years of Non-Current Deferred Tax Liability data on file, last reported at $14000.0 in Q4 2020.

• On a quarterly basis, Non-Current Deferred Tax Liability fell 77.42% year-over-year to $14000.0 in Q4 2020; TTM through Dec 2020 was $14000.0, a 77.42% decrease from a year earlier, with the FY2020 full-year figure at $14000.0, down 77.42% from the prior year.
• Non-Current Deferred Tax Liability for Q4 2020 stood at $14000.0, down from $62000.0 in the prior quarter.
• Over the last five years, Non-Current Deferred Tax Liability for MDGL reached as high as $283000.0 in Q4 2016 and fell as low as $14000.0 in Q4 2020.
• Historically, Non-Current Deferred Tax Liability has averaged $119666.7 across 3 years, with a median of $62000.0 in 2019.
• On a YoY basis, Non-Current Deferred Tax Liability climbed as much as 77.42% in 2020 and fell as far as 77.42% in 2020.
• Year by year, Non-Current Deferred Tax Liability stood at $283000.0 in 2016, then sank by 78.09% to $62000.0 in 2019, then plunged by 77.42% to $14000.0 in 2020.
• Per Business Quant data, the three most recent Non-Current Deferred Tax Liability figures were $14000.0 in Q4 2020, $62000.0 in Q4 2019, and $283000.0 in Q4 2016.